Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
39.39
-0.17 (-0.43%)
At close: Dec 20, 2024, 4:00 PM
39.64
+0.25 (0.63%)
After-hours: Dec 20, 2024, 7:58 PM EST
Moderna Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for Moderna stock have an average target of 79.5, with a low estimate of 40 and a high estimate of 139. The average target predicts an increase of 101.83% from the current stock price of 39.39.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Moderna stock from 19 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 2 | 2 | 3 | 3 |
| Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Hold | 8 | 7 | 10 | 11 | 10 | 11 |
| Sell | 2 | 0 | 1 | 1 | 2 | 3 |
| Strong Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 14 | 15 | 16 | 17 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Argus Research | Argus Research | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 18, 2024 |
| B of A Securities | B of A Securities | Sell Initiates $41 | Sell | Initiates | $41 | +4.09% | Dec 10, 2024 |
| JP Morgan | JP Morgan | Sell Maintains $59 → $45 | Sell | Maintains | $59 → $45 | +14.24% | Nov 26, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $115 → $69 | Buy | Reiterates | $115 → $69 | +75.17% | Nov 18, 2024 |
| HSBC | HSBC | Hold → Strong Buy Upgrades $58 | Hold → Strong Buy | Upgrades | $58 | +47.25% | Nov 18, 2024 |
Financial Forecast
Revenue This Year
3.35B
from 6.85B
Decreased by -51.10%
Revenue Next Year
3.06B
from 3.35B
Decreased by -8.63%
EPS This Year
-9.47
from -12.34
EPS Next Year
-9.17
from -9.47
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 3.8B | 4.5B | 6.1B | |||
| Avg | 3.3B | 3.1B | 3.8B | |||
| Low | 3.0B | 2.4B | 2.7B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -44.0% | 33.5% | 100.1% | |||
| Avg | -51.1% | -8.6% | 24.2% | |||
| Low | -56.5% | -29.7% | -10.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -8.56 | -8.01 | -3.02 | |||
| Avg | -9.47 | -9.17 | -6.91 | |||
| Low | -10.24 | -10.14 | -8.71 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.